3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
2
Pleural Effusion, Malignant
1
Pleural Effusion
1
Neoplasms
1
Multiple Pulmonary Nodules
1
Lung Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Interventions
Cisplatin
28
Paclitaxel
19
Radiotherapy
17
Fluorouracil
13
Drug Therapy
12
camrelizumab
10
toripalimab
8
Carboplatin
8
Radiation
7
Capecitabine
7
Radiotherapy, Intensity-Modulated
6
sintilimab
5
S 1 (combination)
5
Esophagectomy
5
tislelizumab
4
nimotuzumab
4
apatinib
4
anlotinib
4
Irinotecan
4
Cetuximab
4
Afatinib
4
pembrolizumab
3
durvalumab
3
Vinorelbine
3
Positron Emission Tomography Computed Tomography
3
Oxaliplatin
3
Nivolumab
3
Immune Checkpoint Inhibitors
3
Docetaxel
3
Albumin-Bound Paclitaxel
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Esophageal Squamous Cell Carcinoma
×
Thoracoscopy
×
Clear all
NCT02188615
2014-07-11
NACRFMIE
Taizhou Hospital
Phase 2
Unknown
120 enrolled